January 6, 2018 Selection of and evidentiary considerations for wearable devices and their measurements for use in regulatory decision making: recommendations from the ePRO Consortium
January 6, 2018 Informing the tolerability of cancer treatments using patient-reported outcome (PRO) measures: summary of an FDA and Critical Path Institute workshop
January 6, 2018 Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study
January 1, 2018 Development of a symptom-focused patient-reported outcome measure for functional dyspepsia: the Functional Dyspepsia Symptom Diary (FDSD)
December 22, 2017 Application of a Dynamic Map for Learning, Communicating, Navigating, and Improving Therapeutic Development
December 22, 2017 A Dynamic Map for Learning, Communicating, Navigating and Improving Therapeutic Development
December 1, 2017 Duchenne Regulatory Science Consortium Meeting on Disease Progression Modeling for Duchenne Muscular Dystrophy
November 25, 2017 Chronic Pulmonary Insufficiency of Prematurity: Developing Optimal Endpoints for Drug Development
